#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15512	16S	1529	1529	100.0	16S.l6.c30.ctg.1	1992	770.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1422	1422	C	861	C	802	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27444	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3411	800.5	0	.	n	.	0	T695C	SNP	695	695	T	932	932	C	792	C,T	756,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27444	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3411	800.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1574	1574	A	970	A	895	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27444	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3411	800.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2208	2208	C	854	C,A	777,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27444	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3411	800.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2282	2282	A	869	A	800	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27444	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3411	800.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2834	2834	C	856	C	798	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1990	folP	855	855	100.0	folP.l15.c4.ctg.1	1542	128.8	1	SNP	p	R229S	1	.	.	685	687	AGC	961	963	AGC	197;197;195	A;G;C	185;183;182	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5192	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3295	156.9	1	SNP	p	S91F	1	.	.	271	273	TTC	532	534	TTC	184;183;184	T;T;C	169;167;169	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5192	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3295	156.9	1	SNP	p	G95N	0	.	.	283	285	GGC	544	546	GGC	182;180;179	G;G;C	168;166;166	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5192	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3295	156.9	1	SNP	p	D95G	1	.	.	283	285	GGC	544	546	GGC	182;180;179	G;G;C	168;166;166	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1556	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1383	112.3	1	SNP	p	G45D	0	.	.	133	135	GGC	464	466	GGC	222;222;222	G;G;C	207;208;206	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	762	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	987	76.7	0	.	n	.	0	A197.	DEL	197	197	A	611	611	A	186	A	176	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5260	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2882	181.8	1	SNP	p	D86N	0	.	.	256	258	GAC	548	550	GAC	264;262;260	G;A;C	238;236;233	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5260	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2882	181.8	1	SNP	p	R87I	0	.	.	259	261	CGT	551	553	CGT	262;261;259	C;G,A;T	236;233,1;233	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5260	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2882	181.8	1	SNP	p	R87W	0	.	.	259	261	CGT	551	553	CGT	262;261;259	C;G,A;T	236;233,1;233	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5260	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2882	181.8	1	SNP	p	S87R	1	.	.	259	261	CGT	551	553	CGT	262;261;259	C;G,A;T	236;233,1;233	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5260	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2882	181.8	1	SNP	p	S88P	0	.	.	262	264	TCC	554	556	TCC	262;262;262	T;C;C,T	238;237;240,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4224	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2560	164.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1478	1480	GGC	188;184;183	G;G;C	172;165;168	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4070	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2271	178.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1206	1208	GCA	217;218;218	G;C;A	203;203;206	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4070	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2271	178.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1209	1211	ATC	219;218;221	A;T;C	205;204;206	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4070	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2271	178.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1221	1223	GTG	216;214;215	G;T;G	203;198;202	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4070	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2271	178.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1221	1223	GTG	216;214;215	G;T;G	203;198;202	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4070	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2271	178.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1725	1727	ACC	230;233;235	A;C,T;C	213;215,2;220	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4070	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2271	178.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1779	1781	GCG	217;215;214	G;C,A;G	187;166,1;177	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4070	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2271	178.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1779	1781	GCG	217;215;214	G;C,A;G	187;166,1;177	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4070	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2271	178.3	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1902	1904	AGC	187;186;185	A;G;C	170;170;169	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4070	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2271	178.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1911	1913	GGC	185;182;180	G;G,A;C	166;160,1;160	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4070	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2271	178.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1929	1931	CCG	154;158;158	C,G;C,G;G	119,5;123,1;123	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5634	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3087	181.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1689	1691	CCG	216;214;217	C;C;G	196;202;199	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2202	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1746	125.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	604	604	C	156	C	146	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2696	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1675	160.0	0	.	p	.	0	E48G	NONSYN	142	144	GAA	452	454	GGA	247;244;246	G;G;A	231;225;226	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2696	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1675	160.0	0	.	p	.	0	V75I	NONSYN	223	225	GTT	533	535	ATT	214;213;214	A;T;T	199;198;198	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2696	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1675	160.0	0	.	p	.	0	T89S	NONSYN	265	267	ACC	575	577	AGC	203;202;206	A;G;C	194;192;193	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2696	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1675	160.0	0	.	p	.	0	V98I	NONSYN	292	294	GTC	602	604	ATC	213;210;208	A;T;C	200;198;197	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2696	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1675	160.0	0	.	p	.	0	.	MULTIPLE	358	359	AA	667	668	CG	206;203	C;G	185;181	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2696	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1675	160.0	0	.	p	.	0	.	MULTIPLE	361	362	GA	670	672	CAG	205;203;200	C;A;G	184;185;182	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2696	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1675	160.0	0	.	p	.	0	N122K	NONSYN	364	366	AAC	674	676	AAA	200;197;202	A;A;A	182;181;184	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2696	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1675	160.0	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	701	703	TAT	191;193;193	T;A;T	178;181;181	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2696	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1675	160.0	0	.	p	.	0	N134E	NONSYN	400	402	AAT	710	712	GAG	197;198;197	G;A;G	184;184;184	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2696	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1675	160.0	0	.	p	.	0	V135L	NONSYN	403	405	GTG	713	715	CTT	199;201;200	C;T;T	184;186;185	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2696	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1675	160.0	0	.	p	.	0	G140K	NONSYN	418	420	GGA	728	730	AAA	204;204;206	A;A;A	185;185;186	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2696	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1675	160.0	0	.	p	.	0	K143E	NONSYN	427	429	AAA	737	739	GAA	211;211;208	G;A;A	191;190;187	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2696	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1675	160.0	0	.	p	.	0	V151A	NONSYN	451	453	GTA	761	763	GCA	209;211;211	G;C;A	193;193;193	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2696	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1675	160.0	0	.	p	.	0	T213S	NONSYN	637	639	ACA	947	949	TCA	219;221;223	T;C;A	208;210;212	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2696	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1675	160.0	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	1067	1069	CAA	191;192;186	C;A;A,G	181;183;177,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2696	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1675	160.0	0	.	p	.	0	.	INDELS	760	762	ACA	1071	1075	ATCAA	183;184;184;184;182	A;T;C;A,G;A	179;180;180;181,1;180	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2696	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1675	160.0	0	.	p	.	0	.	INDELS	763	764	TG	1078	1080	AGT	185;184;183	A;G;T	182;180;179	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2696	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1675	160.0	0	.	p	.	0	A257D	NONSYN	769	771	GCT	1085	1087	GAT	181;180;182	G;A;T	173;173;175	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2696	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1675	160.0	0	.	p	.	0	T269S	NONSYN	805	807	ACC	1121	1123	AGC	183;181;180	A;G,C;C	172;167,1;167	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2696	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1675	160.0	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1193	1195	AGT	225;226;228	A;G;T	209;207;207	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2696	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1675	160.0	0	.	p	.	0	N295D	NONSYN	883	885	AAC	1199	1201	GAC	234;236;238	G;A;C,A	208;208;214,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2696	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1675	160.0	0	.	p	.	0	H296Y	NONSYN	886	888	CAC	1202	1204	TAC	240;241;245	T;A;C	218;217;221	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2696	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1675	160.0	1	SNP	p	G120K	1	.	.	358	360	AAG	667	669	CGG	206;203;204	C;G;G	185;181;184	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2696	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1675	160.0	1	SNP	p	D121N	0	.	.	361	363	GAC	670	673	CGC	205;200;200	C;G;C	184;182;183	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2696	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1675	160.0	1	SNP	p	A121D	1	.	.	361	363	GAC	670	673	CGC	205;200;200	C;G;C	184;182;183	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11124	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4935	224.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1150	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1056	108.6	1	SNP	p	V57M	1	.	.	169	171	ATG	554	556	ATG	254;252;249	A;T;G	232;228;228	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
